The StageBio team is looking forward to attending the 2022 ESMO Congress Exhibition conference in Paris, France September 9-13, 2022.
Let’s meet in Paris at ESMO! Let us know you are attending by emailing us at email@example.com. Join StageBio and your colleagues, interact with key opinion leaders, ask questions and debate on popular topics in the field of medical oncology. The ESMO conference will provide attendees access to new research, educational and professional development programming and networking opportunities for anyone working in the area of cancer research.
ESMO’s core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up. To create equal access for all patients to obtain care. To educate – doctors, cancer patients and the general public – on the best practices and latest advances in oncology.
See you at ESMO September 9-13, 2022!
Make sure you are familiar with France’s health guidelines on staying safe and preventing the spread of COVID here. For more information on how ESMO plans to stay safe and adhere to safety protocols, click here.
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com.